What is the correct procedure for incorporating the powder from an Entocort capsule into a Colitofalk klysma tube, and are there any galenic stability issues that would prevent preparing a 14-day supply in advance, given that the firma Codali has no experience with this mixture and the klysma has a pH of 5?

How can benzoyl peroxide be incorporated into a solution consisting of 100 mg/g benzoyl peroxide, 1 g salicylic acid, and spiritus up to 100 g?

How is a stable suspension prepared with 50 mg/ml sulfadiazine for the preventive treatment of toxoplasmosis in children?

How can the solubility of caffeine (S=1g/60ml) be increased to achieve a clear solution in a preparation containing 14.5 mg/ml ephedrine and 145 mg/ml caffeine for a total of 30 ml, given that acidification with citric acid is insufficient and results in the formation of a gel-like precipitate over time?

How can a levofloxacin syrup be prepared for a 1-year-old child requiring a dosage of 80 mg twice daily, considering concerns about its extreme bitterness and the lack of existing information on such syrups, or would it be preferable to create capsules to be stirred into fruit porridge since the medication cannot be taken with dairy products?

How can I prevent the discoloration of a cream containing 15 g sulfanilamide, 45 g cod liver oil, 1.5 g vitamin C, 2 cc lemon essence, and 2 cc bergamot essence in Beeler base up to 300 g, given that the resulting brown ointment turns a strong green after two weeks?

Is it necessary to create a fine dispersion in the following preparation to prevent potential precipitation: 30 g Syrup of Codeine 0.2% BF 5, 2 g Tincture of Belladonna, 2 g Laudanum, 3 g ammoniated anise solution BF 5, and water up to 250 ml?